Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma
Composition and Clinical Impact of the Immunologic Tumor Microenvironment in Oral Squamous Cell Carcinoma
复制标题
DOI:
10.4049/jimmunol.1800242
复制
发表时间:
2019-01-01
影响因子:
4.4
通讯作者:
Kolk, Andreas
中科院分区:
文献类型:
--
作者:
Boxberg, Melanie;Leising, Lena;Kolk, Andreas
Immunotherapy shows promising results and revolutionizes treatment of oral squamous cell carcinoma (OSCC). The immunologic microenvironment might have prognostic/predictive implications. Morphologic immunologic parameters (inflammatory infiltrate, stromal content, and budding activity [BA] [potentially indicating epithelial-mesenchymal transition]) were evaluated in 66 human primary therapy-naive OSCCs. Intraepithelial/stromal tumor-infiltrating lymphocytes (TILs; CD3+/CD4+/CD8+/CD4+ FOXP3+/IL-17A(+)) were quantified, and ratios were calculated. HLA class I in tumor cells was evaluated immunohistochemically. mRNA in situ hybridization to detect IFN-gamma was performed. Analysis was performed within invasive front (IF) and tumor center (TCe). Decreased HLA expression was associated with low TIL density, pronounced stromal content, and high BA; IFN-gamma in TILs was correlated with high-density TILs; and IFN-gamma in tumor cells was correlated with absence of BA (p < 0.05). Heterogeneity of parameters (TCe/IF) was rare. Low density of stromal CD4(+)FOXP3(+) TILs within TCe and IF was identified as an independent prognostic factor for poor overall, disease-specific, and disease-free survival (p